1.05
-0.015 (-1.41%)
-0.015 (-1.41%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.015 | -1.41% | 1.05 | 0.00 | 0.00 | 0.00 | 1.065 | 09:21:07 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.05 | 1.07 | 0.02 | 1.87% | - | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 200 | 133,093 | $ 1.06 | $ 141,038 | 18,314,374 | 0.1027 - 2.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:21:17 | 12 | $ 1.05 | USD |
Onconova Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 184.63M | 174.18M | 172.60M | $ 2.18M | $ - | -1.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.17 | 1.22 | 1.025 | 1.11 | 7,236,317 | -0.12 | -10.26% |
| 1 Month | 0.56 | 1.56 | 0.546 | 1.11 | 22,458,524 | 0.49 | 87.5% |
| 3 Months | 0.40 | 1.56 | 0.33 | 0.8118712 | 16,179,425 | 0.65 | 162.5% |
| 6 Months | 0.4399 | 1.56 | 0.273 | 0.6441933 | 13,676,552 | 0.6101 | 138.69% |
| 1 Year | 2.31 | 2.84 | 0.1027 | 0.5300902 | 11,629,565 | -1.26 | -54.55% |
| 3 Years | 30.00 | 42.45 | 0.1027 | 1.32 | 4,336,943 | -28.95 | -96.5% |
| 5 Years | 27.75 | 122.55 | 0.1027 | 2.11 | 2,682,498 | -26.70 | -96.22% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks signaling by targeting RAS effeccellular tor pathways. |
